Cargando…
Identifying the Right Target for New Drugs in Acute Kidney Injury: A Long Way Off?
Autor principal: | Doi, Kent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334450/ https://www.ncbi.nlm.nih.gov/pubmed/37441491 http://dx.doi.org/10.1016/j.ekir.2023.05.025 |
Ejemplares similares
-
Kidney Dysfunction After Acute Heart Failure: Is Acute Kidney Disease the New Acute Kidney Injury?
por: Kwong, Y. Diana, et al.
Publicado: (2021) -
Proximal Tubular Secretion: A New Way to Assess for Kidney Dysfunction?
por: Au, Eric H.K., et al.
Publicado: (2022) -
Long-term risk of sepsis among survivors of acute kidney injury
por: Clark, Edward, et al.
Publicado: (2014) -
Biomarkers in acute kidney injury: On the cusp of a new era?
por: Canney, Mark, et al.
Publicado: (2023) -
The need for disruptive innovation in acute kidney injury
por: Doi, Kent
Publicado: (2020)